These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26446730)

  • 1. Interaction between microRNA expression and classical risk factors in the risk of coronary heart disease.
    Ding XQ; Ge PC; Liu Z; Jia H; Chen X; An FH; Li LH; Chen ZH; Mao HW; Li ZY; Gu Y; Zhu TB; Li CJ; Wang LS; Ma WZ; Yang ZJ; Jia EZ
    Sci Rep; 2015 Oct; 5():14925. PubMed ID: 26446730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between circulating microRNA-208a and severity of coronary heart disease.
    Zhang Y; Li HH; Yang R; Yang BJ; Gao ZY
    Scand J Clin Lab Invest; 2017 Sep; 77(5):379-384. PubMed ID: 28554251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA MALAT1 and its target microRNA-125b associate with disease risk, severity, and major adverse cardiovascular event of coronary heart disease.
    Lv F; Liu L; Feng Q; Yang X
    J Clin Lab Anal; 2021 Apr; 35(4):e23593. PubMed ID: 33660877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between elevated plasma microRNA-223 content and severity of coronary heart disease.
    Guo JF; Zhang Y; Zheng QX; Zhang Y; Zhou HH; Cui LM
    Scand J Clin Lab Invest; 2018 Sep; 78(5):373-378. PubMed ID: 29888618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration in microRNA-155 level correspond to severity of coronary heart disease.
    Qiu XK; Ma J
    Scand J Clin Lab Invest; 2018 May; 78(3):219-223. PubMed ID: 29411649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Effects of Circulating miR-221, miR-130a and miR-155 for Coronary Heart Disease: A Multi-Ethnic Study in China.
    Jia QW; Chen ZH; Ding XQ; Liu JY; Ge PC; An FH; Li LH; Wang LS; Ma WZ; Yang ZJ; Jia EZ
    Cell Physiol Biochem; 2017; 42(2):808-823. PubMed ID: 28628920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating MiR-146a May be a Potential Biomarker of Coronary Heart Disease in Patients with Subclinical Hypothyroidism.
    Quan X; Ji Y; Zhang C; Guo X; Zhang Y; Jia S; Ma W; Fan Y; Wang C
    Cell Physiol Biochem; 2018; 45(1):226-236. PubMed ID: 29357324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNA-33b levels are associated with the presence and severity of coronary heart disease.
    Chen C; Liu Q; Li Y; Yu JW; Wang SD; Xu JL; Liu L
    Scand J Clin Lab Invest; 2024 Apr; 84(2):133-137. PubMed ID: 38597780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis on the association of single nucleotide polymorphism in the promoter region of pre-miR-320b-2 with coronary heart disease risk and factors influencing circulating microRNA-320b level].
    Feng J; Huang S; He M; Dai X; Li J; Deng Q; Qiu G; Yang B; Wu T
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Oct; 48(10):893-9. PubMed ID: 25573129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-155 is inversely associated with severity of coronary stenotic lesions calculated by the Gensini score.
    Zhu GF; Yang LX; Guo RW; Liu H; Shi YK; Ye JS; Yang ZH
    Coron Artery Dis; 2014 Jun; 25(4):304-10. PubMed ID: 24525789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-34a in coronary heart disease: Correlation with disease risk, blood lipid, stenosis degree, inflammatory cytokines, and cell adhesion molecules.
    Li H; Chen M; Feng Q; Zhu L; Bai Z; Wang B; Guo Z; Hou A; Li H
    J Clin Lab Anal; 2022 Jan; 36(1):e24138. PubMed ID: 34861059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease.
    Jansen F; Yang X; Proebsting S; Hoelscher M; Przybilla D; Baumann K; Schmitz T; Dolf A; Endl E; Franklin BS; Sinning JM; Vasa-Nicotera M; Nickenig G; Werner N
    J Am Heart Assoc; 2014 Oct; 3(6):e001249. PubMed ID: 25349183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of serum PCSK9 in CHD patients with the severity of coronary arterial lesions.
    Wang S; Cheng ZY; Zhao ZN; Quan XQ; Wei Y; Xia DS; Li JQ; Hu JL
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1135-9. PubMed ID: 27049268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNA-92a level predicts acute coronary syndrome in diabetic patients with coronary heart disease.
    Wang W; Li Z; Zheng Y; Yan M; Cui Y; Jiang J
    Lipids Health Dis; 2019 Jan; 18(1):22. PubMed ID: 30670045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNA profiles based on direct S-Poly(T)Plus assay for detection of coronary heart disease.
    Su M; Niu Y; Dang Q; Qu J; Zhu D; Tang Z; Gou D
    J Cell Mol Med; 2020 Jun; 24(11):5984-5997. PubMed ID: 32343493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 correlates with microRNA-125b/microRNA-146a/microRNA-203 and predicts 2-year restenosis risk in coronary heart disease patients.
    Zhu Y; Zhu Y; Liu Y; Liu Y; Chen X
    Biomark Med; 2021 Mar; 15(4):257-271. PubMed ID: 33565328
    [No Abstract]   [Full Text] [Related]  

  • 17. The apoB100/apoAI ratio is independently associated with the severity of coronary heart disease: a cross sectional study in patients undergoing coronary angiography.
    Song Y; Yang Y; Zhang J; Wang Y; He W; Zhang X; Zhu J; Lu Z
    Lipids Health Dis; 2015 Nov; 14():150. PubMed ID: 26582246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum miR-3129-5p contributes to the progression of coronary heart disease via targeting mTOR.
    Wang ZY; Zhao T; Zhou J; Gao F
    Kaohsiung J Med Sci; 2021 Apr; 37(4):314-323. PubMed ID: 33336524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Toll-like receptor 4-responsive microRNA panel in patients with coronary artery disease: results from prospective and randomized study of treatment with renin-angiotensin system blockade.
    Satoh M; Takahashi Y; Tabuchi T; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M
    Clin Sci (Lond); 2015 Apr; 128(8):483-91. PubMed ID: 25385173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased alpha-defensin expression is associated with risk of coronary heart disease: a feasible predictive inflammatory biomarker of coronary heart disease in hyperlipidemia patients.
    Maneerat Y; Prasongsukarn K; Benjathummarak S; Dechkhajorn W; Chaisri U
    Lipids Health Dis; 2016 Jul; 15():117. PubMed ID: 27430968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.